Stryker Expands Medical Device Testing Lab in India

Photo:Representative Image

Stryker, a major player in the medical technology space, expanded its prototyping and testing facilities in India on Thursday. According to a press release, this move represents significant growth in our RandD landscape.

This 55,600-square-foot facility will include state-of-the-art, microbiology-intensive facilities. And a talented team to drive innovation and development. Result: We have improved quality across our healthcare technology portfolio.

"Investing in innovation in India is a significant opportunity for Stryker," said Ram Rangarajan, president of Stryker Global Technology Center, India. "This new laboratory demonstrates our commitment to developing medical technologies that improve patient outcomes and meet the highest regulatory standards.

" Ram Rangarajan added, "The expansion of this laboratory further strengthens Stryker's global technology center and represents a significant milestone for our company and our commitment to fostering innovation in India. Stryker will benefit from the homegrown talent and expertise to develop medical technologies that benefit patients worldwide. We intend to develop."

According to a report, 'Molecular Diagnostics: A Pathway to Better Patient Health,' India's molecular diagnostics market is expected to reach $1.6 billion by 2030, driven by growing demand from investors, companies, and startups. The report also highlights new applications in molecular diagnostics for genetics, hematopathology, cardiovascular disease, and neurological disease. Birth control and predictive testing are two important areas in which molecular analysis will play an important role in the future.